A new research paper was published in Volume 16 of Oncotarget on October 13, 2025, titled “Treatment of glioblastoma with tumour-specific...
Vous n'êtes pas connecté
Maroc - THEPARADISE.NG - A La Une - 26/09/2024 23:55
Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis. Current treatments could be more effective. Researchers from the University of Geneva and Geneva University Hospitals have discovered a specific marker on glioblastoma cells and created immune cells called CAR-T cells that can target and destroy these [...] Read Full Article At: Programming cells help to fight a brain tumor
A new research paper was published in Volume 16 of Oncotarget on October 13, 2025, titled “Treatment of glioblastoma with tumour-specific...
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood,...
Scientists have created...
Scientists have created...
By Chidinma Ewunonu-AlukoDr Vincent Osoka, General Surgery Resident at University College Hospital (UCH), Ibadan, emphasises that reducing intake...
By Chidinma Ewunonu-Aluko, Ibadan Dr Vincent Osoka, General Surgery Resident at University College Hospital (UCH), Ibadan, emphasises that...
By Chidinma Ewunonu-Aluko, Ibadan Dr Vincent Osoka, General Surgery Resident at University College Hospital (UCH), Ibadan, emphasises that...
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using...
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using...
In a major breakthrough, scientists at the Indiana University School of Medicine have found a way to transform immune cells that normally protect...